Cargando…
Clinical trials in pediatric ALS: a TRICALS feasibility study
Background: Pediatric investigation plans (PIPs) describe how adult drugs can be studied in children. In 2015, PIPs for Amyotrophic Lateral Sclerosis (ALS) became mandatory for European marketing-authorization of adult treatments, unless a waiver is granted by the European Medicines Agency (EMA). Ob...
Ejemplares similares
-
The French national protocol for Kennedy’s disease (SBMA): consensus diagnostic and management recommendations
por: Pradat, Pierre-François, et al.
Publicado: (2020) -
An Update on Vitamin D and Disease Activity in Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2019) -
Cardiomyopathy and peripheral polyneuropathy severity in patients with Glu89Gln mutation at the time of diagnosis
por: Gospodinova, Mariana, et al.
Publicado: (2015) -
Cardiac involvement and clinical follow up of patients with hereditary transthyretin related amyloidosis associated with Glu89Gln mutation
por: Gospodinova, Mariana, et al.
Publicado: (2015) -
Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations
por: Nakov, Radislav, et al.
Publicado: (2020)